Study #PA17-0577
A study of clinical responses and toxicities to chemotherapies and immunotherapies in urothelial bladder carcinoma and other malignancies in relation to different molecular defects such as MTAP deficiency.
MD Anderson Study Status
Enrolling
Treatment Agent
Description
MTAP gene status for urothelial cancer and other maligancies
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Jianjun Gao
Department:
Genitourinary Medical Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.